Home Cart Sign in  
Chemical Structure| 477202-00-9 Chemical Structure| 477202-00-9

Structure of Ipilimumab
CAS No.: 477202-00-9

Chemical Structure| 477202-00-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ipilimumab is a humanized IgG1 monoclonal antibody that prevents the binding of ligands to CTLA-4 by binding to it. Ipilimumab has potential for research in melanoma.

Synonyms: MDX-010; BMS-734016

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ipilimumab

CAS No. :477202-00-9
M.W : 145.34 kDa
SMILES Code : NONE
Synonyms :
MDX-010; BMS-734016
MDL No. :N/A

Safety of Ipilimumab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04635735 Relapsed/Refractory Multiple M... More >>yeloma Less << PHASE1|PHASE2 TERMINATED 2023-02-02 Memorial Sloan Kettering Baski... More >>ng Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, 11553, United States Less <<
NCT06566391 Melanoma PHASE2 ACTIVE_NOT_RECRUITING 2024-12-31 Istituto Europeo di Oncologia,... More >> Milano, 20141, Italy Less <<
NCT01913691 Merkel Cell Carcinoma PHASE2 WITHDRAWN 2014-02-03 -
NCT02115139 Melanoma|Brain Metastases PHASE2 COMPLETED 2018-07-31 ICO Badalona, Badalona, Spain|... More >>H. Clinic de Barcelona, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|H. Insular de Canarias, Las Palmas de Gran Canaria, Spain|H. U. Gregorio Mara?ón, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Clínica Universidad de Navarra, Pamplona, Spain|H. Clínico de Santiago, Santiago de Compostela, Spain|H.U. Virgen Macarena, Sevilla, Spain|H. Virgen de la Salud, Toledo, Spain|H. General de Valencia, Valencia, Spain|Instituto Valenciano de Oncología, Valencia, Spain Less <<
NCT05074992 Glioblastoma PHASE2 TERMINATED 2023-05-02 Aberdeen Royal Infirmary, Aber... More >>deen, United Kingdom|St Bartholomew's Hospital, London, United Kingdom|University College London Hospital, London, United Kingdom|Queen's Hospital, Romford, United Kingdom Less <<
NCT02516527 Melanoma PHASE1 COMPLETED 2018-09-20 Local Institution, Guangzhou, ... More >>Guangdong, 510060, China Less <<
NCT02050594 Melanoma COMPLETED 2025-02-15 Local Institution, Caracas, Ve... More >>nezuela Less <<
NCT02094391 In-transit Metastases Melanoma... More >> Stage IIIB and IIIC Less << PHASE2 COMPLETED 2025-02-16 Gustave Roussy Cancer Campus G... More >>rand Paris, Villejuif, Val de Marne, 94805, France Less <<
NCT02009384 Metastatic Melanoma PHASE2 TERMINATED 2025-10-14 James Graham Brown Cancer Cent... More >>er, Louisville, Kentucky, 40202, United States Less <<
NCT02224768 Advanced Melanoma COMPLETED 2025-11-15 Bristol-Myers Squibb, Princeto... More >>n, New Jersey, 08540, United States|Local Institution, St. Ives, Cambridgeshire, PE27 5BZ, United Kingdom Less <<
NCT02279862 Prostate Cancer PHASE2 COMPLETED 2016-12-15 San Francisco Oncology Associa... More >>tes, San Francisco, California, 94115, United States|George Washington University Medical Center, Washington, District of Columbia, 20037, United States|Baptist Cancer Institute, Jacksonville, Florida, 32207, United States|Cancer Center Of Kansas, Wichita, Kansas, 67214, United States|North Mississippi Med Center, Tupelo, Mississippi, 38801, United States|Nebraska Cancer Specialists, Omaha, Nebraska, 68130, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Northwest Cancer Specialists, Pc, Tualatin, Oregon, 97062, United States|University of Pittsburgh Cancer Institute Cancer Services, Pittsburgh, Pennsylvania, 15232-1305, United States|Texas Oncology, Houston, Texas, 77024, United States|Virginia Cancer Institute, Richmond, Virginia, 23230, United States|Local Institution, St Leonards, New South Wales, 2065, Australia|Local Institution, Wahroonga, New South Wales, 2076, Australia|Local Institution, Parkville, Victoria, 3050, Australia|Local Institution, Santiago, Metropolitana, Chile|Local Institution, Recoleta, Santiago DE Chile, Chile|Local Institution, Vina Del Mar, Valparaiso, 2540364, Chile|Local Institution, Clermont Ferrand cedex 01, 63011, France|Local Institution, Marseille Cedex 9, 13273, France|Local Institution, Poitiers, France|Local Institution, Rennes Cedex, 35042, France|Local Institution, Saint Herblain, 44805, France|Local Institution, Villejuif, 94805, France|Universitaetsklinikum Aachen, Aachen, 52074, Germany|Uniklinik Heidelberg, Heidelberg, 69120, Germany|Universitaetsklinikum Jena, Jena, 07743, Germany|Universitaetsklinikum Magdeburg, Magdeburg, 39120, Germany|Universitaetsklinikum Mannheim, Mannheim, 68167, Germany|Local Institution, Marktredwitz, 95615, Germany|Klinikum rechts der Isar der TU, Muenchen, 81675, Germany|Urologische Praxis, Rostock, 18107, Germany|Urologische Gemeinschaftspraxis Dres Stammel U. Garcia, Wesel, 46483, Germany|Dgu Urologie, Wuppertal, 42103, Germany|Local Institution, Milano, 20133, Italy|Istituto Nazionale Tumori Fondazione Pascale, Napoli, 80131, Italy|Local Institution, Amsterdam, 1081 HV, Netherlands|Local Institution, Barcelona, 08035, Spain|Local Institution, Hospitalet de Llobregat - Barcelona, 08908, Spain|Local Institution, Sevilla, 41009, Spain|Local Institution, Valencia, 46009, Spain|Local Institution, Glasgow, Lanarkshire, G12 0YN, United Kingdom|Local Institution, Nottingham, Nottinghamshire, NG5 1PB, United Kingdom|Local Institution, Guildford, Surrey, GU2 7XX, United Kingdom Less <<
NCT00362713 Urothelial Carcinoma PHASE1 COMPLETED 2025-10-09 The University Of Texas MD And... More >>erson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT00083278 Breast Cancer|Adenocarcinoma PHASE2 COMPLETED 2025-02-06 Sharp Clinical Oncology Resear... More >>ch, San Diego, California, 92123, United States|Wishard Health Services, Indianapolis, Indiana, 46202-2859, United States|Section of Hematology/Oncology, Indiana Cancer Pavilion, Indianapolis, Indiana, 46202-5289, United States|Indiana University, Clarian Health Partners, Indianapolis, Indiana, 46202, United States|Medical Arts Building, Jeffersonville, Indiana, 47130, United States|Kansas City Oncology and Hematology Group, Kansas City, Kansas, 66112, United States|Kansas City Oncology and Hematology Group, Overland Park, Kansas, 66210, United States|LaGrange, LaGrange, Kentucky, 40031, United States|Norton Healthcare Inc, Loiusville Oncology Clinical Research Program, Louisville, Kentucky, 40202, United States|Suburban Medical Plaza II, Louisville, Kentucky, 40207, United States|Audubon Oncology/Hematology, Louisville, Kentucky, 40217, United States|Kansas City Oncology and Hematology Group, Kansas City, Missouri, 64131, United States|Kansas City Oncology and Hematology Group, Lee's Summit, Missouri, 64064, United States|Arlington Cancer Center, Arlington, Texas, 76012, United States Less <<
NCT00162123 Melanoma PHASE2 COMPLETED 2025-04-14 University Of Arizona Cancer C... More >>enter, Tucson, Arizona, 85719, United States|Wilshire Oncology Medical Group Inc, Laverne, California, 91750, United States|The Angeles Clinic & Research Inst., Los Angeles, California, 90025, United States|Usc/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|San Francisco Oncology Associates, San Francisco, California, 94115, United States|Local Institution, To come, Connecticut, United States|Baptist Cancer Institute, Jacksonville, Florida, 32207, United States|University Of Chicago, Chicago, Illinois, 60637, United States|Indiana Oncology Hematology Consultants, Indianapolis, Indiana, 46202, United States|Washington University School Of Medicine, Saint Louis, Missouri, 63110, United States|St Joseph Oncology Inc, St Joseph, Missouri, 64507, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Carolinas Medical Center, Charlotte, North Carolina, 28203, United States|The Christ Hospital Cancer Center Research, Cincinnati, Ohio, 45219, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Cancer Centers Of The Carolinas, Greenville, South Carolina, 29615, United States|Center For Oncology Research & Treatment, P.A., Dallas, Texas, 75230, United States|Joe Arrington Cancer Research And Treatment Center, Lubbock, Texas, 79410, United States|University Of Washington Medical Center, Seattle, Washington, 98109, United States|Local Institution, Buenos Aires, CP1280AEB, Argentina|Local Institution, Wels, A-4600, Austria|Local Institution, Wien, 1090, Austria|Local Institution, Brussels, 1070, Belgium|Local Institution, Brussels, 1090, Belgium|Local Institution, Bruxelles, 1200, Belgium|Local Institution, Porto Alegre, Rio Grande Do Sul, 90050, Brazil|Local Institution, Porto Alegre, Rio Grande Do Sul, 90610, Brazil|Local Institution, Jau, Sao Paulo, 17210, Brazil|Local Institution, Calgary, Alberta, T2N 4N2, Canada|Local Institution, Edmonton, Alberta, T6G 1Z2, Canada|Local Institution, Moncton, New Brunswick, E1C 6Z8, Canada|Local Institution, Olomouc, 775 20, Czech Republic|Local Institution, Aarhus C, 8000, Denmark|Local Institution, Brest, 29200, France|Local Institution, Lyon Cedex 08, 69373, France|Local Institution, Paris, 75010, France|Local Institution, Vandoeuvre Les Nancy, 54511, France|Local Institution, Berlin, D-12200, Germany|Local Institution, Heidelberg, 69120, Germany|Local Institution, Kiel, D-24105, Germany|Local Institution, Jerusalem, 91120, Israel|Local Institution, Tel-Aviv, 64239, Israel|Local Institution, Genova, 16132, Italy|Local Institution, Meldola (Fc), 47014, Italy|Local Institution, Rimini, 47900, Italy|Local Institution, Siena, 53100, Italy|Local Institution, Oslo, 0310, Norway|Local Institution, Lodz, 90553, Poland|Local Institution, Poznan, 61-866, Poland|Local Institution, Wroclaw, 51-124, Poland|Local Institution, St. Petersburg, 191104, Russian Federation|Local Institution, Stavropol, 355047, Russian Federation|Local Institution, Voronezh, 394000, Russian Federation|Local Institution, Johannesburg, Gauteng, 2199, South Africa|Local Institution, Cape Town, Western Cape, 7570, South Africa|Local Institution, Malaga, 29010, Spain|Local Institution, Valencia, 46009, Spain|Local Institution, Dnepropetrovsk, 49044, Ukraine Less <<
NCT04196452 Melanoma ACTIVE_NOT_RECRUITING 2029-06-30 Local Institution, Princeton, ... More >>New Jersey, 08540, United States Less <<
NCT00323882 Prostate Cancer|Neoplasm Metas... More >>tasis Less << PHASE1|PHASE2 COMPLETED 2025-07-13 The Angeles Clinic and Researc... More >>h Institute, Los Angeles, California, 11818, United States|The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94115, United States|Yale University School of Medicine, New Haven, Connecticut, 06520, United States|Josephine Ford Cancer Center-Downriver, Brownstown, Michigan, 48183, United States|Henry Ford Medical Center-Fairlane, Dearborn, Michigan, 48126, United States|Henry Ford Hospital, Detroit, Michigan, 48202-2689, United States|Henry Ford Medical Center-West Bloomfield, West Bloomfield, Michigan, 48322, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, United States|Carolina BioOncology Institute, Huntersville, North Carolina, 28078, United States|Oregon Health and Science University, Portland, Oregon, 97239-3098, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States Less <<
NCT02115243 Unresectable Melanoma PHASE1 COMPLETED 2015-12-07 Duke University Medical Center... More >>, Durham, North Carolina, 27707, United States Less <<
NCT02113657 Prostate Cancer EARLY_PHASE1 COMPLETED 2019-11-04 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT00495066 Melanoma NO_LONGER_AVAILABLE - Instituto éTICA - AMO - Assist... More >>ência Multidisciplinar em Oncologia, Salvador, Bahia, 41950-610, Brazil|Instituto do Cancer do Ceara, Fortaleza, Ceara, 60930-230, Brazil|Hospital Sao Lucas das PUCRS, Porto Alegre, Rio Grande do Sul (RS), 90610-000, Brazil|Hospital Mae de Deus, Porto Alegre, Rio Grande do Sul (RS), 90840440, Brazil|Amaral Carvalho hospital, Jau, Sao Paulo, 17210-120, Brazil|Fundacao Pio XI - Hospital De Cancer De Barretos, Barretos, SP, 14784-400, Brazil|Hospital A. C. Camargo, Sao Paulo, SP, 01509-900, Brazil|Hospital Sao Jose - Beneficencia Portuguesa - Oncology Center, Sao Paulo, SP, CEP 01321-001, Brazil|Instituto Nacional de Cancer - INCA, Rio de Janeiro, 20231-050, Brazil Less <<
NCT01445379 Sarcoma|Wilm's Tumor|Lymphoma|... More >>Neuroblastoma Less << PHASE1 COMPLETED 2015-11-13 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10021, United States Less <<
NCT01688492 Prostate Cancer PHASE1|PHASE2 ACTIVE_NOT_RECRUITING 2025-09-25 Northwestern University, Evans... More >>ton, Illinois, 60208, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States Less <<
NCT01355120 Ocular Melanoma PHASE2 COMPLETED 2025-09-13 Universit?tsklinikum Erlangen ... More >>Hautklinik, Erlangen, Bayern, 91052, Germany|Klinikum Nürnberg Nord, Nürnberg, Bayern, 90419, Germany|Klinikum Kassel GmbH, Kassel, Hessen, 34125, Germany|Klinikum Dorothea Christiane Erxleben Quedlinburg gGmbH, Quedlinburg, Sachsen-Anhalt, 06484, Germany|Universit?tsklinikum Schleswig-Holstein, Campus Lübeck, Universit?tsklinikum Klinik f.Dermatologie, Allegologie u.Venerologie, Lübeck, Schleswig-Holstein, 23538, Germany|Charité Universit?tsmedizin Berlin, Campus Mitte, Berlin, 10117, Germany|Krankenhaus Buxtehude, Buxtehude, 21614, Germany|Helios Klinikum Erfurt, Erfurt, 99089, Germany|University Hospital Essen, Essen, 45122, Germany|Klinikum der Johann Wolfgang Goethe Universit?t, Frankfurt am Main, 60590, Germany|Universit?tsklinikum Heidelberg Hautklinik, Heidelberg, 69115, Germany|Universit?tsklinikum des Saarlandes, Homburg, Homburg/Saar, 66421, Germany|Klinik Universit?tsklinikum Jena Klinik f. Hautkrankheiten, Jena, 07743, Germany|Universit?tsklinikum Schleswig-Holstein, Campus Kiel, Kiel, 24105, Germany|Universit?tsklinik K?ln, Koeln, 50937, Germany|Universit?tsklinikum Leipzig Dermatologie, Leipzig, 04103, Germany|Klinikum der Stadt Ludwigshafen am Rhein gGmbH, Ludwigshafen, 67063, Germany|Universit?tsmedizin der Johannes Gutenberg-Universit?t Mainz, Mainz, 55131, Germany|Universit?tsklinikum Mannheim gGmbH, Medizinische Fakult?t Mannheim derUniversit?t Heidelberg, Mannheim, 68167, Germany|Johannes Wesling Klinikum Minden, Minden, 32429, Germany|Fachklinik Hornheide, Muenster, 48157, Germany|Ludwig-Maximilians-Universit?t München, München, 80337, Germany|Universit?tsklinikum Münster Klinik u.Poliklinik f.Hautkrankheiten, Münster, Germany|Univ.-Klinikum Regensburg, Regensburg, 93053, Germany|Universit?tshautklinik Tuebingen, Tuebingen, 72076, Germany Less <<
 

Historical Records

Categories